|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on
which registered
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
|
|
☒
|
Smaller reporting company
|
||
|
Emerging growth company
|
|
PART I. FINANCIAL INFORMATION
|
||
|
Item 1.
|
F-2
|
|
|
F-2
|
||
|
F-3
|
||
|
F-4
|
||
|
F-5
|
||
|
F-6
|
||
|
Item 2.
|
25
|
|
|
Item 3.
|
28
|
|
|
Item 4.
|
28
|
|
|
PART II. OTHER INFORMATION
|
||
|
Item 1.
|
29
|
|
|
Item 1A.
|
29
|
|
|
Item 2.
|
29
|
|
|
Item 3.
|
30
|
|
|
Item 4.
|
30
|
|
|
Item 5.
|
30
|
|
|
Item 6.
|
31
|
|
|
32
|
||
| Item 1. |
Interim Financial Statements
|
|
September 30,
2022
|
December 31,
2021
|
|||||||
| (unaudited) |
||||||||
|
ASSETS
|
||||||||
|
Current assets
|
|
|||||||
|
Cash
|
$ | $ | ||||||
|
Prepaid insurance
|
||||||||
| Total current assets | ||||||||
|
Investment held in Trust Account
|
||||||||
|
Long-term prepaid insurance
|
||||||||
|
Total Assets
|
$
|
|
$ | |||||
|
LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
|
||||||||
|
Current Liabilities
|
||||||||
| Accounts payable | $ | $ | ||||||
|
Accrued expenses
|
|
|||||||
|
Franchise tax payable
|
||||||||
| Income tax payable |
||||||||
|
Due to related party
|
||||||||
|
Total current liabilities
|
|
|||||||
|
Deferred underwriting fee payable
|
||||||||
|
Warrant liabilities
|
||||||||
| Total liabilities | ||||||||
|
Commitments and Contingencies
|
||||||||
|
Class A common stock subject to possible redemption, $
|
||||||||
|
Stockholders’ Deficit
|
||||||||
|
Preferred Stock - $
|
|
|||||||
|
Common Stock Class A - $
|
|
|||||||
|
Common Stock Class B - $
|
|
|||||||
|
Additional paid-in capital
|
|
|||||||
|
Accumulated deficit
|
(
|
)
|
( |
) | ||||
|
Total stockholders’ deficit
|
(
|
)
|
( |
) | ||||
|
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit
|
$
|
|
$ | |||||
|
For the Three
Months Ended
September 30, 2022
|
For the Three
Months Ended
September 30, 2021
|
For the Nine
Months Ended
September 30, 2022
|
For thee Period
from
April 1, 2021
(Inception)
through
September 30,
2021
|
|||||||||||||
|
Formation costs and other operating expenses
|
$
|
|
$ |
$
|
|
$
|
|
|||||||||
|
Franchise tax expense
|
|
|
|
|||||||||||||
|
Loss from operations
|
(
|
)
|
( |
) |
(
|
)
|
(
|
)
|
||||||||
|
Other income (expense):
|
||||||||||||||||
|
Income earned on marketable securities held in Trust Account
|
|
|
|
|||||||||||||
|
Warrant offering expense
|
( |
) | ( |
) | ||||||||||||
|
Offering costs related to transferring founder shares to anchor investors
|
( |
) | ( |
) | ||||||||||||
|
Change in fair value of warrant liabilities
|
|
( |
) |
|
(
|
)
|
||||||||||
|
Net income (loss) before provision for income taxes
|
( |
) | ( |
) | ||||||||||||
|
Provision for income taxes
|
||||||||||||||||
|
Net income (loss)
|
$
|
|
$ | ( |
) |
$
|
|
$
|
(
|
)
|
||||||
|
Weighted average Class A common stock outstanding, basic and diluted
|
|
|
|
|||||||||||||
|
Basic and diluted net income (loss) per share, Class A
|
$
|
|
$ | ( |
) |
$
|
|
$
|
(
|
)
|
||||||
|
Weighted average Class B common stock outstanding, basic and diluted
|
|
|
|
|||||||||||||
|
Basic and diluted net income (loss) per share, Class B
|
$
|
|
$ | ( |
) |
$
|
|
$
|
(
|
)
|
||||||
|
Class B
Common Stock
|
Additional |
Accumulated |
Total
Stockholders’
|
|||||||||||||||||
|
Shares
|
Amount
|
Paid-in Capital
|
Deficit
|
Deficit
|
||||||||||||||||
|
Balances as of December 31, 2021
|
|
$
|
|
$ |
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||
|
Net income
|
—
|
|
|
|
|
|||||||||||||||
|
Balances as of March 31, 2022 (unaudited)
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
|
Net income
|
—
|
|
|
|
|
|||||||||||||||
|
Balances as of June 30, 2022 (unaudited)
|
|
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||
| Net income | — | |||||||||||||||||||
| Accretion of Class A ordinary shares subject
to redemption |
— | ( |
) | ( |
) | |||||||||||||||
| Balances as of September 30, 2022 (unaudited) |
$ |
$ | $ |
( |
) | $ |
( |
) | ||||||||||||
|
Class B
Common Stock
|
Additional |
Accumulated |
Total
Stockholders’
Equity
|
|||||||||||||||||
|
Shares
|
Amount
|
Paid-in Capital
|
Deficit
|
(Deficit)
|
||||||||||||||||
|
Balances as of April 1, 2021 (inception)
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||
|
Issuance of Class B common stock to Sponsor
|
|
|
|
|
|
|||||||||||||||
|
Net loss
|
—
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
|
Balances as of June 30, 2021 (unaudited)
|
|
|
|
|
|
|
(
|
)
|
|
|
||||||||||
|
Excess of cash received over fair value of private placement warrants
|
— | — | — | |||||||||||||||||
| Forfeiture of Class B common stock |
( |
) | ( |
) | — | — | ||||||||||||||
| Accretion for Class A common stock to redemption amounts |
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||
| Net loss | — | — | — | ( |
) | ( |
) | |||||||||||||
| Balances as of September
30, 2021 (unaudited) |
$ |
$ | $ |
( |
) | $ |
( |
) | ||||||||||||
| For the Period | ||||||||
| from April 1, | ||||||||
| For the Nine |
2021 (Inception) | |||||||
| Months Ended |
through | |||||||
| September 30, 2022 | September 30, 2021 | |||||||
|
Cash flow from operating activities:
|
||||||||
|
Net income (loss)
|
$
|
|
$ | ( |
) | |||
|
Adjustments to reconcile net income (loss) to net cash used in operating activities:
|
||||||||
|
Interest earned on marketable securities held in trust account
|
( |
) | ||||||
|
Change in fair value of warrant liabilities
|
|
|||||||
|
Offering expenses - warrants and anchor investors
|
( |
|||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Prepaid insurance
|
( |
) | ||||||
|
Accounts payable
|
||||||||
|
Accrued expenses
|
(
|
)
|
||||||
|
Franchise tax payable
|
||||||||
|
Income tax payable
|
||||||||
|
Due to related party
|
|
|||||||
|
Net Cash used in Operating Activities
|
(
|
)
|
( |
) | ||||
|
Cash flow from investing activities:
|
||||||||
|
Investment held in Trust Account
|
( |
) | ||||||
|
Net Cash used in Investing Activities
|
( |
) | ||||||
|
Cash flow from financing activities:
|
||||||||
|
Proceeds received from initial public offering
|
||||||||
|
Proceeds from Promissory note payable
|
||||||||
|
Repayments of Promissory note payable
|
( |
) | ||||||
|
Proceeds from private warrants
|
||||||||
|
Payment of offering costs
|
( |
) | ||||||
| Net Cash used in Financing Activities | ||||||||
|
Net change in cash
|
(
|
)
|
||||||
|
Cash at the beginning of the period
|
|
|||||||
|
Cash at the end of the period
|
$
|
|
$ | |||||
|
Non-cash investing and financing activities:
|
||||||||
|
Offering costs included in accrued offering costs
|
$ | $ | ||||||
|
Deferred underwriting commissions
|
$ | $ | ||||||
|
Offering costs paid by Sponsor in exchange for issuance of Class B common stock
|
$ | $ | ||||||
|
Offering costs included in Due to Sponsor
|
$ |
$ | ||||||
|
For the Three Months Ended
September 30, 2022
|
For the Three Month Ended
September 30, 2021
|
For the Nine Months ended
September 30, 2022
|
For the Period
from April 1,
2021 (inception)
through September 30, 2021
|
|||||||||||||||||||||||||||||
|
Class A
|
Class B
|
Class A | Class B | Class A | Class B | Class A |
Class B
|
|||||||||||||||||||||||||
|
EPS
|
||||||||||||||||||||||||||||||||
|
Numerator: Net income (loss)
|
||||||||||||||||||||||||||||||||
|
Allocation of net income (loss)
|
$
|
|
$
|
|
$ | ( |
) | $ | ( |
) | $ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||
|
Denominator:
|
||||||||||||||||||||||||||||||||
|
Basic and diluted weighted average shares outstanding
|
|
|
||||||||||||||||||||||||||||||
|
Basic and diluted net income (loss) per common stock
|
$
|
|
$
|
|
$ | ( |
) | $ | ( |
) | $ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||||
|
Gross Proceeds
|
$
|
|
||
|
Less:
|
||||
|
Proceeds allocated to Public Warrants
|
(
|
)
|
||
|
Class A common stock issuance costs
|
(
|
)
|
||
|
Add:
|
||||
|
Accretion of carrying value to redemption value
|
|
|||
|
Class A common stock subject to possible redemption at December 31, 2021
|
|
|
||
|
Accretion of carrying value to redemption value
|
||||
| Class A common stock subject to possible redemption at September 30, 2022 |
$ |
|
●
|
in whole and not in part;
|
| ● |
at a price of $
|
| ● |
upon a minimum of
|
| ● |
if, and only if, the last reported sale price of the Class A common stock equals or exceeds $
|
|
●
|
in whole and not in part;
|
| ● |
at a price of $
|
| ● |
upon a minimum of
|
| ● |
if, and only if, the last reported sale price of the Class A common stock equals or exceeds $
|
| ● |
if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current
prospectus relating thereto available throughout the
|
| ● |
if, and only if, the last reported sale price of the Company’s Class A common stock is less than $
|
|
|
As of September 30,
|
As of December 31,
|
||||||||||
|
Description
|
Level
|
2022
|
2021
|
|||||||||
|
Assets:
|
||||||||||||
|
Investments held in Trust Account
|
1
|
$
|
|
$
|
|
|||||||
|
Liabilities:
|
||||||||||||
|
Private Placement Warrants
|
3
|
$
|
|
$
|
|
|||||||
|
Public Warrants
|
2
|
$
|
|
$
|
|
|||||||
| Public Warrants |
1 | $ | $ | |||||||||
|
Input
|
As of December 31,
2021
|
|||
|
Risk-free interest rate
|
|
%
|
||
|
Expected term (years)
|
|
|||
|
Expected volatility
|
|
%
|
||
|
Exercise price
|
$
|
|
||
|
Public stock price
|
$
|
|
||
| • |
The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants.
|
| • |
The expected life of the warrants is assumed to be equivalent to their remaining contractual term.
|
| • |
The Company estimates the volatility of its shares of common stock based on historical volatility that matches the expected remaining life of the warrants.
|
| • |
The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.
|
|
Input
|
As of September 30,
2022
|
|||
|
Risk-free interest rate
|
|
%
|
||
|
Expected term (years)
|
|
|||
|
Expected volatility
|
|
%
|
||
|
Exercise price
|
$
|
|
||
|
Public stock price
|
$
|
|
||
|
|
Private Placement
Warrants
|
|||
|
Fair value as of December 31, 2021
|
$
|
|
||
|
Change in valuation inputs or assumptions(1)
|
(
|
)
|
||
|
Fair value as of March 31, 2022
|
|
|
||
|
Change in valuation inputs or assumptions(1)
|
( |
) | ||
|
Fair value as of June 30, 2022
|
||||
| Change in valuation inputs or assumptions(1) | ( |
) | ||
| Fair value as of September 30, 2022(2) | $ | |||
| (1) |
|
| (2) |
|
| ITEM 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
| ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
| ITEM 4. |
CONTROLS AND PROCEDURES.
|
| ITEM 1. |
LEGAL PROCEEDINGS.
|
| ITEM 1A. |
RISK FACTORS.
|
| ITEM 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
|
| ITEM 3. |
DEFAULTS UPON SENIOR SECURITIES.
|
| ITEM 4. |
MINE SAFETY DISCLOSURES.
|
| ITEM 5. |
OTHER INFORMATION.
|
| ITEM 6. |
EXHIBITS
|
|
Exhibit
Number
|
Description
|
|
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
101.INS*
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
|
|
|
101.SCH*
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
|
101.CAL*
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
101.DEF*
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
101.LAB*
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
101.PRE*
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
104*
|
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document, which is contained in Exhibit 101).
|
|
AXONPRIME INFRASTRUCTURE ACQUISITION CORPORATION
|
|
|
Date: November 18, 2022
|
/s/ Dinakar Singh
|
|
Dinakar Singh
|
|
|
Chief Executive Officer and Principal Financial Officer
|
|
|
(Duly Authorized and Principal Executive Officer)
|